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Abstract
The purpose of this study was to compare invasively measured aorta flow with 2D phase contrast flow and 4D flow measure-
ments by cardiovascular magnetic resonance (CMR) imaging in a large animal model. Nine swine (mean weight 63 ± 4 kg) 
were included in the study. 4D flow CMR exams were performed on a 1.5T MRI scanner. Flow measurements were performed 
on 4D flow images at the aortic valve level, in the ascending aorta, and main pulmonary artery. Simultaneously, flow was 
measured using an invasive flow probe, placed around the ascending aorta. Additionally, standard 2D phase contrast flow 
and 2D left ventricular (LV) volumetric data were used for comparison. The correlations of cardiac output (CO) between 
the invasive flow probe, and CMR modalities were strong to very strong. CO measured by 4D flow CMR correlated better 
with the CO measured by the invasive flow probe than 2D flow CMR flow and volumetric LV data (4D flow CMR: Spear-
man’s rho = 0.86 at the aortic valve level and 0.90 at the ascending aorta level; 2D flow CMR: 0.67 at aortic valve level; LV 
measurements: 0.77). In addition, there tended to be a correlation between mean pulmonary artery flow and aorta flow with 
4D flow (Spearman’s rho = 0.65, P = 0.07), which was absent in measurements obtained with 2D flow CMR (Spearman’s 
rho = 0.40, P = 0.33). This study shows that aorta flow can be accurately measured by 4D flow CMR compared to simultane-
ously measured invasive flow. This helps to further validate the quantitative reliability of this technique.
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Introduction
Cardiovascular magnetic resonance (CMR) imaging has 
been used for flow visualization and quantification in daily 
clinical practice for several decades [1, 2]. CMR is the gold 
standard for non-invasive quantification of left and espe-
cially right heart function and shunt fraction [3, 4]. Nowa-
days, standard imaging protocols consists of the acquisition 
of cine imaging and 2D phase contrast flow measurements 
in multiple planes using numerous breath-holds. Especially, 
in complex congenital heart disease patients this can be chal-
lenging and time consuming.
A promising and rapidly evolving CMR technique is 4D 
flow imaging: a volumetric, free-breathing acquisition tech-
nique of flow velocity data with simultaneous assessment 
of anatomic structures [5]. 4D flow CMR allows flow quan-
tification at any level within the acquired field of view and 
calculation of cardiac volumes and biventricular function 
[6, 7]. Until now, several studies have evaluated the use of 
4D flow CMR for visualization and quantification of car-
diac shunts [8–11]. 4D flow CMR was previously validated 
against echocardiography [12] and standard 2D flow CMR 
in humans [13, 14]. In addition, the 4D flow determined 
pulmonary vascular resistance was validated against in vivo 
measurements in a canine study [15].
In this study, we sought to validate this promising 4D 
flow CMR technique by direct, simultaneous comparison 
with 2D flow CMR and invasive flow measurements using a 
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validated flow probe positioned around the ascending aorta 
in a large animal model.
Methods
Study design
Studies were performed in accordance with the “Guiding 
Principles in the Care and Use of Laboratory Animals” as 
approved by the Council of the American Physiological 
Society, and with approval of the Animal Care Committee of 
the Erasmus Medical Center Rotterdam (3158, 109-13-09). 
Nine Yorkshire x Landrace swine (5–6 months old, 21 ± 1 kg 
at the time of surgery, 63 ± 4 kg at the time of the CMR scan) 
of either sex were included in the study. The swine included 
in this study were part of previously published studies [16, 
17].
Chronic instrumentation of the swine
The swine were chronically catheterized for hemodynamic 
monitoring approximately 2 to 3 months prior to the scan-
ning procedure. Surgical details have been extensively 
described previously [18]. In short, swine were sedated with 
an intramuscular injection of tiletamine/zolazepam (5 mg/
kg), xylazine (2.25 mg/kg) and atropine (1 mg), intubated 
and ventilated with a mixture of  O2 and  N2 (1:2 v/v) to 
which 2% (v/v) isoflurane was added to maintain anesthe-
sia. Under sterile conditions, the chest was opened via a left 
thoracotomy in the fourth intercostal space and fluid-filled 
polyvinylchloride catheters (B Braun Medical Inc., Bethle-
hem, PA, USA) were placed in the right ventricle, pulmo-
nary artery, aorta and left atrium. A flow probe (Transonic 
Systems Inc., Ithaca, NY, USA) was positioned around the 
ascending aorta for measurement of aorta flow. The catheters 
were tunneled to the back and animals received analgesia 
(0.015 mg/kg buprenorphine i.m. and a slow-release fentanyl 
patch 12 μg/h for 48 h) on the day of the surgery and daily 
antibiotic prophylaxis (25 mg/kg amoxicillin i.v.) for 7 days.
CMR protocol
CMR examination was performed on a 1.5T clinical scan-
ner with a dedicated receive-only 32-channel phased-array 
cardiac surface coil (Discovery MR450, GE Healthcare, 
Milwaukee, WI, USA). The animals were sedated, and 
intubated as described above. Anesthesia during imaging 
was maintained with pentobarbital sodium (6–12 mg/kg/h). 
Mechanical ventilation and breath-holds were performed 
using a mobile ventilator (Carina™, Dräger Medical, Best, 
The Netherlands). Heart rate (HR) and blood pressures 
were monitored throughout the scan. When necessary, and 
always in absence of pain reflexes, muscle relaxation was 
achieved using pancuronium bromide (2–4 mg bolus). The 
image protocol consisted of 2D balanced Steady-State Free 
Precession (SSFP) cine imaging, 4D flow, and 2D phase 
contrast flow measurements. Standard long-axis and short-
axis images with full left ventricular (LV) coverage were 
acquired using retrospectively ECG-gated SSFP cine imag-
ing with breath-holding (FIESTA, GE Healthcare acronym). 
Typical scan parameters were slice thickness 6.0 mm, slice 
gap 0 mm, TR/TE 3.4/1.4 ms, flip angle (FA) 75°, field 
of view (FOV) 320 × 240 mm, acquired matrix 128 × 180, 
and reconstructed to a pixel size of 1.3 × 1.3 mm. The free-
breathing, retrospectively ECG-gated 4D flow acquisition 
was performed directly after administration of a gadolin-
ium-based contrast agent (Gadovist 1.0 mmol/mL, Bayer, 
Mijdrecht, The Netherlands, single dose of up to 15 mL). 
The 4D flow sequence has been described before [11–13], 
in short the sequence was prescribed in axial plane, includ-
ing the entire thorax in the field of view. The k-space was 
filled with variable-density Poisson-disc undersampling 
with acceleration factors of 1.8 × 1.8 (phase × slice) and the 
parallel imaging algorithm used was ESPIRiT. The follow-
ing imaging parameters were used: matrix 192 × 160 × 78, 
acquired resolution 2.1 × 1.7 × 2.8 mm, reconstructed resolu-
tion 2.1 × 1.7 × 1.4 mm, TR/TE 3.8/1.5 ms, FA 15°, views 
per segment 4, bandwidth 63 kHz, number of reconstructed 
phases 20 per cardiac cycle, and a velocity encoded value set 
at 250 cm/s. Scan time ranged between 5.57 and 8.51 min. 
Finally, one-directional through plane 2D phase contrast 
flow measurements of the aorta (at the level of the aortic 
valve or just above) and pulmonary artery were performed 
during an end-expiratory breath-hold. The imaging planes 
were planned perpendicular to the great vessels. Typical scan 
parameters were slice thickness 6.0 mm, matrix 256 × 166, 
TR/TE 4.0/2.2 ms, FA 18°, FOV 340 × 220, velocity encod-
ing value set at 180 cm/s. The invasive flow probe was 
attached to the amplifier and a flow signal was obtained 
immediately before and after the 4D flow CMR sequence.
Post‑processing and data analysis
To assess left ventricular volumes, endocardial contours 
were drawn manually on end-diastolic and end-systolic 2D 
short axis SSFP cine images, and stroke volume and ejection 
fraction were calculated. No substantial mitral regurgitation 
was visually noted on CMR in any of the animals, therefore 
stroke volume (mL/beat) and cardiac output (CO, L/min) of 
the left ventricle were also compared to invasive measure-
ments. To analyze the 2D phase contrast images a region of 
interest was manually traced around the aorta and pulmonary 
valve. Both 2D flow CMR and left ventricular function were 
analyzed with Medis software (QMass and QFlow analyti-
cal software version 8.1, Medis, Leiden, The Netherlands).
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The 4D flow data were analyzed using a dedicated cloud-
based post-processing software (ArterysInc, San Francisco, 
CA, USA). Semi-automatic eddy-current correction was 
applied [13]. Data were visualized, and flow quantification 
was performed at the level of aortic valve and at the level 
of the sinotubular junction/proximal part of the ascending 
aorta below the flow probe. Also the pulmonary flow was 
determined by measuring in the main pulmonary artery 
(MPA). For both 2D and 4D flow shunt fractions (Qp/Qs) 
were calculated.
Digital recording and offline analysis of HR and aorta 
flow were performed with MatLab (MathWorks, Natick, 
MA, USA) and have been described in detail elsewhere [19, 
20]. Briefly, HR and aorta flow were analyzed offline using 
a proprietary program written in MatLab. Over at least 10 
consecutive seconds, both before and after the 4D flow CMR 
sequence, CO and SV were determined from each individual 
beat and averaged. HR was calculated as the ratio of the 
number of beats and time. The end-diastolic time point was 
used to align the (average) phasic flow signals obtained with 
the different methods.
All analyses were performed independently from each 
other (2D flow and left ventricular function measurements 
by NvdV and AH, 4D flow CMR by RC, and invasive flow 
probe measurements by KS).
Statistics
Statistical analysis was performed with SPSS software ver-
sion 21 (IBM, NewYork, US) and Graphpad Prism 4 Project 
(San Diego, CA, US). Correlation between measurements 
was evaluated using Spearman’s (rho) coefficient for nonpar-
ametric data, and agreement was analyzed with Bland–Alt-
man plots. The Spearman rho coefficient was classified as 
“very weak” for values of 0.00–0.19, “weak” for 0.20–0.39, 
“moderate” for 0.40–0.59, “strong” for 0.60–0.79 and “very 
strong” for 0.80–1.0 [11, 21].
Results
A total of nine animals were scanned, but not all animals 
were included in every method of CO determination: two 
animals had a malfunctioning invasive flow probe, in all nine 
animals CO could be determined with 4D flow CMR at the 
level of the aortic valve, while susceptibility artefacts from 
the invasive flow probe precluded measurement of CO at the 
ascending aorta level in two animals. Finally, one animal 
was excluded due to technical problems for measurement of 
CO with 2D flow CMR as well as LV functional measure-
ments. Typical examples of the 4D flow CMR images and 
measurements are shown in Fig. 1 and supplemental video’s.
The shape of the individual aorta flow patterns meas-
ured by all three methods showed good agreement and 
individual flow curves per animal are depicted in Fig. 2. 
Indeed, the correlation between the CO measured by the 
invasive flow probe and 4D flow CMR was very strong 
(Spearman’s rho = 0.86 at the aortic valve level and 0.90 
at the ascending aorta level) (Table 1 and Fig. 3). Rela-
tive to the invasive flow probe measurements, the flow 
Fig. 1  Example of 4D flow 
CMR images and measurement
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measured by 4D flow CMR was overestimated by 0.8 
L/min at the aortic valve level and by 0.6 L/min at the 
ascending aorta level (Bland–Altman, Table 1 and Fig. 3). 
The correlation between the invasive flow probe and 2D 
flow CMR and volumetric LV measurements were strong 
(2D flow CMR: Spearman’s rho = 0.67 and volumetric LV 
measurements: Spearman’s rho = 0.77). Relative to the 
invasive flow probe measurements, the flow measured 
by 2D flow CMR was overestimated by 1.1 L/min and 
by 1.3 L/min with the LV parameters (Bland–Altman, 
Table 1 and Fig. 3).  
The correlation between the 4D flow CMR and 2D 
f low CMR MPA CO measurement was very strong 
(Spearman’s rho = 0.81) (Table 1). Relative to the 4D 
flow CMR measurements, the MPA CO measured by 2D 
flow CMR was underestimated by 0.4 L/min. Although 
the correlation between MPA and aorta flow at the aortic 
valve level as measured with 4D flow CMR only tended to 
be significant (Spearman’s rho = 0.65, P = 0.07), no corre-
lation was found between MPA and aorta flow measured 
with 2D flow CMR (Spearman’s rho = 0.40, P = 0.33) 
(Fig. 4).
Discussion
The main findings of this study were that (1) CO measured 
by 4D flow CMR showed a very strong correlation with 
invasively measured aortic flow, although there was an 
overestimation of the CO by 4D flow CMR of ~ 16%, (2) 
the correlation between 2D flow CMR and volumetric LV 
measurements in relation to invasively measured flow was 
less strong with a larger overestimation of the flow, and 
(3) the difference between MPA and aorta flow was much 
smaller with 4D flow compared to 2D flow CMR.
4D flow CMR is a relatively new technique but increas-
ingly used in clinical practice due to its simplicity. The 
application of 4D flow CMR in the clinical setting pro-
vides many benefits as the technique is patient and opera-
tor friendly, less operator dependent and any flow in any 
plane can be selected retrospectively [8, 12, 22]. The latter 
is not the case for 2D flow CMR, in which flow meas-
urements are limited to preselected planes [12, 22, 23]. 
Importantly, 4D flow CMR is in most cases more patient 
friendly than 2D flow CMR. One important benefit for 
Fig. 2  Individual aorta flow curves per heartbeat of the invasive flow 
probe, 4D flow CMR (measured at level of the aortic valve), and 2D 
flow CMR superimposed per animal. 2D flow CMR measurements of 
animal 7 and invasive flow probe measurements of animal 8 and 9 are 
missing due to technical problems
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the patients is that the sequence can be performed with-
out breath holds (free breathing), which is not only more 
comfortable but will be an advantage in children and 
decompensated patients in which breath holds are mostly 
impossible [11, 12, 22]. In addition, data on flow and ana-
tomic structures can be obtained simultaneously which 
can shorten the scan time for the patients, especially in 
patients with a difficult anatomy [11, 13, 22, 24]. However, 
it is important to note that there are some existing chal-
lenges with the 4D flow CMR technique such as long scan 
time, reliability of respiratory gating and lower resolution. 
Given the benefits and existing challenges, it is important 
to assess accuracy of 4D flow CMR measurements. Our 
data show that indeed, 4D flow CMR measurements cor-
relate strongly with flow measured with an invasive flow 
probe, and overestimation of flow with this technique is 
less than measurements obtained using 2D flow CMR as 
well as compared to CO determined from volumetric LV 
measurements.
This is the first study to validate 4D flow CMR against 
both 2D flow CMR and invasively measured flow within 
the same animal, at the same time. Thus far, 4D flow CMR 
has only been validated against 2D flow CMR [13, 14] and 
ultrasound [12] measurements in humans. Although data 
are obtained in a relatively small group of animals, and 
magnetic interference of the metal in the flow probe could 
not be completely ruled out (two animals were excluded 
due to artifacts and in the other animals there were no 
noticeable imaging artifacts), both flow pattern and aver-
age flow showed a very strong correlation between inva-
sively measured flow and 4D flow CMR. Although the 
invasively measured flow is considered the gold stand-
ard in validation studies, according to the manufacturer’s 
specifications, this technique has an absolute accuracy of 
Table 1  Summary of flow 
measurements with the different 
methods
MPA main pulmonary artery, SV stroke volume, CO cardiac output
a Invasive flow probe measurements are taken as reference for the aortic flow measurements; 4D flow CMR 
measurements are taken as reference for the main pulmonary artery and Qp:Qs measurements
Method Mean ± SD n Spearman’s  rhoa Bland–Altman
Bias ± 1.96 SD
Invasive flow probe
 Heart rate (beats/min) 98 ± 16 7
 SV ascending aorta (mL/beat) 62 ± 15 7
 CO ascending aorta (L/min) 5.0 ± 1.2 7
4D flow CMR
 Heart rate (beats/min) 98 ± 16 9
 SV aortic valve (mL/beat) 62 ± 14 9 0.86 − 8 − 23 to 6
 CO aortic valve (L/min) 6.0 ± 1.4 9 0.86 − 0.8 − 2.1 to 0.5
 SV ascending aorta (mL/beat) 56 ± 17 7 1.00 − 7 − 20 to 6
 CO ascending aorta (L/min) 5.6 ± 1.5 7 0.90 − 0.6 − 1.8 to 0.6
 SV MPA (mL/beat) 58 ± 15 9
 CO MPA (L/beat) 5.6 ± 1.3 9
 Qp:Qs 0.9 ± 0.1 9
2D flow CMR
 Heart rate aortic valve (beats/min) 99 ± 20 8
 SV aortic valve (mL/beat) 62 ± 17 8 0.71 − 12 − 40 to 16
 CO aortic valve (L/min) 5.9 ± 1.4 8 0.67 − 1.1 − 3.7 to 1.5
Heart rate MPA (beats/min) 102 ± 24 8
SV MPA (mL/beat) 54 ± 21 8 0.60 − 3 − 32 to 27
 CO MPA (L/min) 5.1 ± 1.5 8 0.81 − 0.4 − 2.7 to 2.0
 Qp:Qs 0.9 ± 0.3 8 0.10 0.0 − 0.6 to 0.5
Left ventricular parameters
 Heart rate (beats/min) 103 ± 29 8
 End-diastolic volume (mL) 138 ± 32 8
 End-systolic volume (mL) 75 ± 25 8
 Ejaction fraction (%) 46 ± 9 8
 SV (mL/beat) 63 ± 16 8 0.94 − 12 − 28 to 4
 CO (L/min) 6.3 ± 1.4 8 0.77 − 1.3 − 3.3 to 0.6
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10%. Both 2D flow CMR and 4D flow CMR overestimated 
CO as compared to the invasively measured flow by 25% 
and 16% respectively. When comparing the individual 
flow patterns between the different techniques (Fig. 2) we 
do not see a consistent difference between the CMR and 
invasively measured flow, suggesting that there is no sys-
tematic bias. Consistent with data obtained in a canine 
model of acute thromboembolic pulmonary hypertension, 
4D flow CMR resulted in slightly lower values of CO as 
compared to 2D flow CMR measurements [15], suggest-
ing that determination of flow using 4D CMR is slightly 
more accurate than 2D CMR. The higher accuracy of 4D 
flow CMR vs 2D flow CMR can also be inferred from the 
comparison between aorta flow and MPA flow. Also here, 
Fig. 3  Comparison of cardiac 
output in the aorta measured 
by the invasive flow probe, 4D 
flow and 2D flow CMR Cor-
relation between the invasive 
flow probe, 4D flow CMR (a 
n = 7), and 2D flow CMR (c 
n = 6) measurements of the 
aortic flow. Line of identity is 
indicated as the dotted line and 
Spearman’s rho (ρ) and P value 
are indicated in the legends (a, 
c). Bland–Altman plots of the 
cardiac output (CO), with the 
mean, 1.96 standard devia-
tion (SD) and -1.96 SD lines 
indicated as the dotted lines. b 
invasive flow probe and 4D flow 
CMR measurements (n = 7), 
and d invasive flow probe and 
2D flow CMR measurements 
(n = 6)
Fig. 4  Comparison of pul-
monary artery and aorta flow 
measured by 4D flow and 2D 
flow CMR Correlation between 
the aorta and pulmonary artery 
flow measured by 4D flow 
CMR (a, n = 9) and 2D flow 
CMR (b, n = 8). Line of identity 
is indicated as the dotted line. 
Spearman’s rho (ρ) and P-value 
are indicated in the legends
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there tended to be a correlation of the measurements with 
4D flow CMR while no correlation was found with 2D 
flow CMR.
In conclusion, this study shows that aorta flow and pul-
monary flow can be accurately and simultaneously measured 
by 4D flow CMR. This helps to further validate the quantita-
tive reliability of this technique for implementation of 4D 
flow CMR in routine clinical practice.
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